ATTR-CM

The latest news about ATTR-CM: headlines, AI summaries and the full story from every source.

• Alnylam Shares Drop After AstraZeneca Posts Negative Trial Data Seeking Alpha · August 28, 2026, 12:59 UTC
• BridgeBio Stock Rises Following AstraZeneca and Ionis' Failed Heart Drug Trial Yahoo Finance · July 9, 2026, 23:38 UTC
• BridgeBio Stock Surges Following AstraZeneca and Ionis' Failed Heart Drug Trial TheStreet · July 9, 2026, 20:38 UTC
• Alnylam Pharmaceuticals Reports Record Q1 Revenue Driven by AMVUTTRA Growth Yahoo Finance · April 30, 2026, 20:45 UTC